Search Results - "Morosi, L"

Intratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity by Fuso Nerini, I, Morosi, L, Zucchetti, M, Ballerini, A, Giavazzi, R, D'Incalci, M

“…We provide an overview of the available information on the distribution of chemotherapeutics in human tumors, highlighting the progress made to assess the…”
Get full text

3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors by Giordano, S., Morosi, L., Veglianese, P., Licandro, S. A., Frapolli, R., Zucchetti, M., Cappelletti, G., Falciola, L., Pifferi, V., Visentin, S., D’Incalci, M., Davoli, E.

“…Mass Spectrometry Imaging (MSI) is a widespread technique used to qualitatively describe in two dimensions the distribution of endogenous or exogenous…”
Get full text

Differential protein profiling of renal cell carcinoma urinary exosomes by Raimondo, F, Morosi, L, Corbetta, S, Chinello, C, Brambilla, P, Della Mina, P, Villa, A, Albo, G, Battaglia, C, Bosari, S, Magni, F, Pitto, M

“…Renal cell carcinoma (RCC) accounts for about 3% of all human malignancies and its incidence is increasing. There are no standard biomarkers currently used in…”
Get more information

Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer by Ansaloni, L, Coccolini, F, Morosi, L, Ballerini, A, Ceresoli, M, Grosso, G, Bertoli, P, Busci, L M, Lotti, M, Cambria, F, Pisano, M, Rossetti, D, Frigerio, L, D'Incalci, M, Zucchetti, M

“…Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) is advised as a treatment option for epithelial ovarian cancer (EOC) with peritoneal…”
Get full text

Urinary exosomes and diabetic nephropathy: a proteomic approach by Raimondo, F, Corbetta, S, Morosi, L, Chinello, C, Gianazza, E, Castoldi, G, Di Gioia, C, Bombardi, C, Stella, A, Battaglia, C, Bianchi, C, Magni, F, Pitto, M

“…Urinary exosomes (UE) are nanovesicles released by every epithelial cell facing the urinary space and they are considered a promising source of molecular…”
Get more information

671: Inhibition of angiogenesis promotes a homogeneous intra-tumor distribution of chemotherapy associated with better antitumor response by Cesca, M, Morosi, L, Zucchetti, M, Frapolli, R, Giordano, S, Richter, P, Dirsch, O, Bernd, A, Giavazzi, R

Get full text

Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment by Croci, Diego O, Cerliani, Juan P, Pinto, Nicolas A, Morosi, Luciano G, Rabinovich, Gabriel A

“…Abnormal glycosylation is a typical hallmark of the transition from healthy to neoplastic tissues. Although the importance of glycans and glycan-binding…”
Get full text

Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples by Raimondo, F, Morosi, L, Chinello, C, Perego, R, Bianchi, C, Albo, G, Ferrero, S, Rocco, F, Magni, F, Pitto, M

“…Renal cell carcinoma (RCC) is representing about 3% of all adult cancers. A promising strategy for cancer biomarker discovery is subcellular comparative…”
Get more information

Plasma sex steroid and thyroid hormones profile in male water frogs of the Rana esculenta complex from agricultural and pristine areas by Mosconi, G., Di Rosa, I., Bucci, S., Morosi, L., Franzoni, M.F., Polzonetti-Magni, A.M., Pascolini, R.

“…Some chemical compounds used in intensive agriculture have been found to induce estrogenic effects; therefore a histological analysis of the testes and an…”
Get full text

PO-76 The T3R domain of thrombospondin-1 delays tumor growth and improves tumor response to chemotherapy by remodeling the tumor vasculature by Pinessi, D., Resovi, A., Morosi, L., Borsotti, P., Berndt, A., Giavazzi, R., Zucchetti, M., Taraboletti, G.

Get full text

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts by Demuytere, Jesse, Carlier, Charlotte, Van de Sande, Leen, Hoorens, Anne, De Clercq, Kaat, Giordano, Silvia, Morosi, Lavinia, Matteo, Cristina, Zucchetti, Massimo, Davoli, Enrico, Van Dorpe, Jo, Vervaet, Chris, Ceelen, Wim

“…Epithelial ovarian cancer is associated with high mortality due to diagnosis at later stages associated with peritoneal involvement. Several trials have…”
Get full text

DOP88 Lipids drive myofibroblast activation and the epithelial-mesenchymal transition process in Crohn’s Disease by Rizzo, G, Wozny, M, Pineda Chavez, S E, Mori, G, Carriles Linares, A, Morosi, L, Martano, G, Ghisletti, S M L, Gandolfi, F, Vallelonga, V, Loy, L, Bezzio, C, Spaggiari, P, Dal Buono, A, Gabbiadini, R, Carvello, M, Spinelli, A, Repici, A, Armuzzi, A, Vetrano, S

“…Abstract Background Fibrostenosis represents one of the major clinical complications of Crohn’s Disease (CD). However, the molecular mechanisms underlying…”
Get full text

Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: Results of a randomized, controlled trial by MARCHIONNI, Niccolo, FATTIROLLI, Francesco, FUMAGALLI, Stefano, OLDRIDGE, Neil, DEL LUNGO, Francesco, MOROSI, Linda, BURGISSER, Costanza, MASOTTI, Giulio

“…Whether cardiac rehabilitation (CR) is effective in patients older than 75 years, who have been excluded from most trials, remains unclear. We enrolled…”
Get full text

85P Whole-genome CRISPR screening identifies chemosensor receptors as key regulators of the cancer-macrophage crosstalk by Marelli, G., Morina, N., Iovino, M., Puccio, S., Carvetta, M., Morosi, L., Martano, G., Paraboschi, E., Lazzeri, M., Colombo, P., Casale, P., Peano, C., Marchini, S., Lugli, E., Di Mitri, D.

Get full text